ABSI: Absci Corporation Stock

SIC 8731 – Commercial Physical and Biological Research

Valuation
Market Cap ($M) 587.47
Enterprise Value ($M) 523.02
Book Value ($M) 176.18
Book Value / Share 1.56
Price / Book 3.33
NCAV ($M) 79.46
NCAV / Share 0.70
Price / NCAV 7.39

Profitability (mra)
Return on Invested Capital (ROIC) -0.58
Return on Assets (ROA) -0.37
Return on Equity (ROE) -0.44

Liquidity (mrq)
Quick Ratio 4.08
Current Ratio 4.08

Balance Sheet (mrq) ($M)
Current Assets 120.58
Assets 217.30
Liabilities 41.12
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 5.72
Operating Income -93.68
Net Income -110.57

Cash Flow Statement (mra) ($M)
Cash From Operations -64.64
Cash from Investing 81.94
Cash from Financing -4.48

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
03-05 13D/A Redmile Group, LLC 7.40 3.12
02-14 13G/A Phoenix Venture Partners II LP 15.50 -0.78
02-13 13G McClain Sean 10.00 3.19
02-09 13G/A Fmr Llc 14.91 0.02
05-08 13D/A Casdin Capital, LLC 4.80 -19.61

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-21 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-30 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1
2023-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-01 96,133 303,926 31.63
2024-04-30 59,836 174,420 34.31
2024-04-29 75,988 205,700 36.94

(click for more detail)

Similar Companies
ICLR – ICON Public Limited Company INCY – Incyte Corporation
MEDP – Medpace Holdings, Inc. MXCT – MaxCyte, Inc.
NRC – National Research Corporation


Financial data and stock pages provided by
Fintel.io